Page last updated: 2024-10-27

fluorouracil and Epidermodysplasia Verruciformis

fluorouracil has been researched along with Epidermodysplasia Verruciformis in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Epidermodysplasia Verruciformis: An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.

Research Excerpts

ExcerptRelevanceReference
"Epidermodysplasia verruciformis is a rare genodermatosis characterized by a unique susceptibility to cutaneous human papillomaviruses infection."1.40Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report. ( Honda, M; Kato, T; Kawase, M; Mitsuishi, T; Yoshida, R, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshida, R1
Kato, T1
Kawase, M1
Honda, M1
Mitsuishi, T1

Other Studies

1 other study available for fluorouracil and Epidermodysplasia Verruciformis

ArticleYear
Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
    BMC dermatology, 2014, Jul-21, Volume: 14

    Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antiviral Agents; Epidermodysplasia Verruciformis; Fema

2014